Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 9:07 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 169–192 of 2,510 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: RAPID Clear all

Conditions: Working Memory
Interventions: Transcranial alternating current stimulation (tACS); Device
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 45 Years
Enrollment: 34 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: COVID-19 Testing Behaviors
Interventions: COVID-19 rapid test-to-treat, Standard COVID19 education control arm; Behavioral
Lead sponsor: University of Missouri, Kansas City; Other
Eligibility: 18 Years to 120 Years
Enrollment: 900 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Major Depressive Disorder
Interventions: Memantine; Drug
Lead sponsor: Mclean Hospital; Other
Eligibility: 55 Years to 89 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Belmont, Massachusetts

Conditions: Healthy
Interventions: OROS methylphenidate hydrochloride, methylphenidate hydrochloride; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 55 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Otorhinolaryngologic Surgical Procedures, Laser Therapy
Interventions: THRIVE, Endotracheal tube; Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Stanford, California

Conditions: Obesity, Childhood
Interventions: protein-sparing modified fast diet; Other
Lead sponsor: Ihuoma Eneli; Other
Eligibility: 11 Years to 19 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Lupus Nephritis
Interventions: LUPKYNIS, belimumab, obinutuzumab or anifrolumab, mycophenolic acid analog (MPAA), corticosteroid; Drug · Biological
Lead sponsor: Aurinia Pharmaceuticals Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 27
States / cities: La Mesa, California • Los Alamitos, California • Arvada, Colorado + 23 more

Conditions: Diabetes Mellitus, Type 2
Interventions: Insulin Pump (Medtronic Minimed Paradigm® VEO); Device
Lead sponsor: Medtronic MiniMed, Inc.; Industry
Eligibility: 30 Years to 75 Years
Enrollment: 331 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 3
States / cities: Atlanta, Georgia • Albany, New York • Syracuse, New York

Conditions: Facial Skin Aging, Facial Volume Loss, Wrinkle Appearance
Interventions: GLP-1 Receptor Agonists; Drug
Lead sponsor: Ponsky Facial Aesthetics And Plastic Surgery, Llc; Industry
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Beachwood, Ohio

Conditions: Immunotherapy-related Pruritus
Interventions: TriCalm Hydrogel®, Triamcinolone acetonide 0.1% cream; Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Respiratory Tract Infections, Influenza, Human, Common Cold
Interventions: Rapid respiratory pathogen nucleic acid amplification test; Device
Lead sponsor: University of California, Davis; Other
Eligibility: 1 Year to 101 Years
Enrollment: 194 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Gastric Antral Vascular Ectasia, Cirrhosis, Chronic Kidney Disease
Interventions: Gastric Emptying Breath Test; Diagnostic Test
Lead sponsor: Mayo Clinic; Other
Eligibility: 19 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Cleft Lip and Palate
Interventions: Maxillary Protraction, Orthognathic Surgery; Procedure
Lead sponsor: University of Southern California; Other
Eligibility: 11 Years to 21 Years
Enrollment: 117 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2021
U.S. locations: 2
States / cities: Los Angeles, California • Seattle, Washington

Conditions: Cerebrovascular Accident
Interventions: TR intervention, In-home messaging device., Usual care; Behavioral
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 45 Years to 90 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 3
States / cities: Decatur, Georgia • Indianapolis, Indiana • Durham, North Carolina

Conditions: HIV, Hepatitis C
Interventions: Questionnaire, Rapid finger stick, Venipuncture; Behavioral · Procedure
Lead sponsor: Boston Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Sarcopenia
Interventions: DXA scanning; Radiation
Lead sponsor: George Washington University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 34 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Posttraumatic Stress Disorder, Tinnitus
Interventions: resting-state functional MRI, Clinician Administered PTSD Scale for the DSM-5 (CAPS-5), Tympanometry, Tinnitus Assessment, Otoscopy, Pure tone air and bone-conduction, Speech testing, Loudness Discomfort, Quick Speech in Noise Test, Distortion-Product Otoacoustic Emissions (DPOAE); Diagnostic Test
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years and older
Enrollment: 64 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Prostate Cancer, Prostate Cancer Metastatic
Interventions: Fasting, Ketone Supplementation; Behavioral · Dietary Supplement
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 18 Years and older · Male only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Gastric Ultrasound, Glucagon-like Peptide 1, Point of Care Ultrasound
Interventions: Gastric Ultrasound Exam; Other
Lead sponsor: Hospital for Special Surgery, New York; Other
Eligibility: 18 Years to 99 Years
Enrollment: 354 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 7
States / cities: Washington D.C., District of Columbia • Jacksonville, Florida • Albany, New York + 2 more

Conditions: Hookworm Infection, Hookworm Disease
Interventions: Na-GST-1/Alhydrogel®, CpG 10104; Biological
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 18 Years to 50 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Fundamental Adaptive Skills Training, Relaxation and Mindfulness Training
Interventions: Fundamental Adaptive Skills Training, Relaxation and Mindfulness Training; Behavioral
Lead sponsor: Florida State University; Other
Eligibility: 18 Years and older
Enrollment: 105 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Tallahassee, Florida

Conditions: Vaccine Uptake
Interventions: Communication Campaign; Behavioral
Lead sponsor: Syracuse University; Other
Eligibility: Not listed
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Syracuse, New York

Conditions: Coronary Artery Disease
Interventions: PET-MPI Protocol, CT-MPI, Coronary CT angiography (CCTA) for CT-FFR calculation, Regadenoson; Diagnostic Test · Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: HIV Infections, Sexually Transmitted Diseases, Viral, Syphilis
Interventions: mLab App Plus; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 39 Years · Male only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 2
States / cities: New York, New York • Nashville, Tennessee

Search by objective public record fields.

Traveling-wave Transcranial Electric Stimulation

COVID-19 Rapid Test-to-Treat With African American Churches (Faithful Response II)

Treatment Resistant Geriatric Depression in Primary Care

Study Examining Repeat Dosing of OROS® Methylphenidate (CONCERTA®) and Immediate Release Methylphenidate in Healthy Adults

Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) and Laser Laryngeal Surgery

A Protein-sparing Modified Fast for Children and Adolescents With Severe Obesity (PSMF)

PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis

OpT2mise Glucose Control in Type 2 Diabetes Mellitus (DM) With Insulin Pump Therapy

Comparing Facial Aging Between Identical Twins With 3D Imaging

TriCalm Hydrogel® in the Treatment of Immunotherapy-Related Pruritus

Rapid Diagnostics for Upper Respiratory Infections in the Emergency Department

Prevalence of Gastric Motor Dysfunction and Upper GI Symptoms in Gastric Antral Vascular Ectasias

Clinical Effectiveness of Late Maxillary Protraction for Cleft Lip and Palate

Home-based Telehealth Stroke Care: A Randomized Trial for Veterans

Integrating HCV and HIV Screening During the Era of HIV Antigen Testing

Muscle Ultrasound for Sarcopenia Leading to Early Detection

Neurobiological Similarities of Tinnitus and PTSD

7-Days Water-Only Fasting or Ketone Supplementation Trial in Prostate Cancer

Gastric Ultrasound Assessment for Patients Taking GLP1 Agonists

Safety and Immunogenicity Study of Na-GST-1 With or Without CpG

The Fundamental Adaptive Skills Training

Boosting COVID-19 Vaccination Uptake Using Wastewater Surveillance

The MATCH Investigation: CT Myocardial Perfusion and CT-FFR vs PET MPI

mLab App Plus: A Randomized Controlled Trial of a Mobile Health (mHealth) Intervention